Takeda Pharmaceutical Company Limited (NYSE:TAK – Get Free Report) shares hit a new 52-week low on Thursday . The stock traded as low as $13.08 and last traded at $13.11, with a volume of 294162 shares trading hands. The stock had previously closed at $13.23.
Takeda Pharmaceutical Price Performance
The company has a market capitalization of $41.25 billion, a P/E ratio of 19.75, a price-to-earnings-growth ratio of 2.98 and a beta of 0.53. The company’s 50-day moving average price is $14.06 and its two-hundred day moving average price is $14.20. The company has a debt-to-equity ratio of 0.64, a current ratio of 1.06 and a quick ratio of 0.55.
Takeda Pharmaceutical (NYSE:TAK – Get Free Report) last issued its quarterly earnings data on Thursday, February 1st. The company reported $0.51 earnings per share for the quarter. Takeda Pharmaceutical had a net margin of 6.90% and a return on equity of 12.57%. The company had revenue of $7.52 billion for the quarter. As a group, sell-side analysts expect that Takeda Pharmaceutical Company Limited will post 1.5 EPS for the current year.
Hedge Funds Weigh In On Takeda Pharmaceutical
Takeda Pharmaceutical Company Profile
Takeda Pharmaceutical Company Limited engages in the research, development, manufacture, marketing, and out-licensing of pharmaceutical products in Japan and internationally. It offers pharmaceutical products in the areas of gastroenterology, rare diseases, plasma derived therapies, immunology, oncology, and neuroscience.
Further Reading
- Five stocks we like better than Takeda Pharmaceutical
- Dividend Payout Ratio Calculator
- 3 Stocks Leading the U.S. Agriculture Comeback
- 3 Small Caps With Big Return Potential
- How to Use Put Debit Spreads to Profit From Falling Stocks
- Health Care Stocks Explained: Why You Might Want to Invest
- Alphabet Changes the Narrative with Its First-Ever Dividend
Receive News & Ratings for Takeda Pharmaceutical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Takeda Pharmaceutical and related companies with MarketBeat.com's FREE daily email newsletter.